CAMK2A and lung adenocarcinoma: Evidence indicates that CAMK2A promotes tumor-initiating capacity in lung adenocarcinoma by enhancing SOX2 expression through EZH2 phosphorylation, highlighting its complex involvement in tumor biology (Wang et al., 2020).